IRADIMED CORPORATION IRMD
85.23 USD -1.35 (-1.56%)
At closeNov 13, 2026, 5:44 AM EST
85.03 -0.20 -0.23%
Pre-market · Nov 13, 5:44 AM ET
85.07 Day range 87.46
76.35 52-week range 107.90
- YTD
- -12.39%
- 1 year
- -1.39%
Benzinga news
benzinga.com iRadimed Q3 2026 Earnings Call Transcript iRadimed (NASDAQ:IRMD) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com iRadimed Q3 Adj. EPS $0.55, Inline, Sales $24.203M Beat $23.467M Estimate iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.55 per share which met the analyst consensus estimate. This is a 17.02 percent increase over earnings of $0.47 per share from the same period…
benzinga.com iRadimed Lowers FY2026 Adj EPS Guidance from $2.09-$2.24 to $2.07-$2.11 vs $2.11 Est; Narrows FY2026 Sales Guidance from $91.000M-$96.000M to $91.600M-$93.100M vs $92.133M Est iRadimed (NASDAQ:IRMD) lowers FY2026 Adj EPS guidance from $2.09-$2.24 to $2.07-$2.11 vs $2.11 analyst estimate. Narrows FY2026 sales outlook from $91.000 million-$96.000 million to $91.600…
benzinga.com iRadimed Sees Q4 Adj EPS $0.57-$0.61 vs $0.63 Est; Sees Sales $25.000M-$26.500M vs $26.233M Est iRadimed (NASDAQ:IRMD) is looking for Q4 Adj EPS of $0.57-$0.61 vs $0.63 analyst estimate. sees sales of $25.000 million-$26.500 million vs $26.233 million analyst estimate.